Role of the Gut Sweet Taste Receptor in the Secretion of Satiation Peptides
NCT01302574 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2011-02-24
Summary
The purpose of this study is to determine the functional significance of sweet taste receptors in the secretion of gastrointestinal (GI) satiation peptides by using a specific sweet taste receptor antagonist to block sweet taste perception in the gastrointestinal tract.
Conditions
- Taste Disorder, Secondary, Sweet
Interventions
- DIETARY_SUPPLEMENT
-
lactisole
Lactisole-liquid meal: Lactisole (450 ppm) will be mixed with a liquid meal. Liquid meal only: The comparator will be the liquid meal alone.
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Christoph Beglinger, MD · Phase 1 Research Unit, University Hospital Basel
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2010-03-31
- Completion
- 2010-06-30
Countries
- Switzerland
Study Locations
More Related Trials
-
Fiber Tolerability in Children
NCT02519374 ·Status: COMPLETED ·Phase: NA
-
The Use of DPP-4 Inhibitors in Short Bowel Syndrome
NCT02653131 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Monosodium Glutamate Supplementation on Gastric Emptying and Postprandial Nitrogen Kinetics
NCT00862017 ·Status: COMPLETED ·Phase: NA
-
Neocate In Infants and Children With Complex Conditions
NCT04265729 ·Status: UNKNOWN ·Phase: NA
-
Palatability of Oral Rehydration Solutions
NCT00689312 ·Status: COMPLETED ·Phase: PHASE3
-
Desensitization to Reduce Oral Hypersensitivity and Improve Intake for Children With Feeding Disorders
NCT03739047 ·Status: COMPLETED ·Phase: NA
-
Mechanisms of Action for the Enterra Medical Gastric Electrical Stimulator
NCT06582576 ·Status: RECRUITING
-
Effects on Crying Time in Colicky Infants With the Supplementation of Lactobacillus Reuteri DSM 17938
NCT02574065 ·Status: UNKNOWN ·Phase: NA
-
Domperidone for Relief of Gastrointestinal Disorders
NCT00761254 ·Status: TERMINATED ·Phase: NA
-
Domperidone in Refractory Gastroparesis
NCT00760461 ·Status: TERMINATED ·Phase: PHASE2
-
Tolerability and Modulatory Action of the Butyrate Releaser N-(1-carbamoyl-2-phenyl-ethyl) Butyramide
NCT04491266 ·Status: COMPLETED ·Phase: NA
-
Lactobacillus Reuteri for the Treatment of Infantile Colic:
NCT01046617 ·Status: COMPLETED ·Phase: PHASE3
-
The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS)
NCT00728104 ·Status: WITHDRAWN
-
Tolerance of an Oral Nutritional Supplement(ONS)
NCT01782456 ·Status: COMPLETED ·Phase: NA
-
Use of Prokinetics in Early Enteral Feeding in Preterm Infants
NCT01569633 ·Status: WITHDRAWN ·Phase: NA
-
Effectiveness of Folic Acid Supplementation in Acute Watery Diarrhea Among Children Under 5 Years of Age
NCT04782037 ·Status: UNKNOWN ·Phase: PHASE4
-
Uptake and Utilization of Amino Acids by Splanchnic Bed
NCT01032616 ·Status: COMPLETED ·Phase: PHASE1
-
Role of Topical Steroid Injection With Refractory Benign Esophageal Stricture Endoscopic Dilatation in Children
NCT06514079 ·Status: RECRUITING ·Phase: NA
-
Improved Quality of Life in Children With Intestinal Failure
NCT04981262 ·Status: COMPLETED ·Phase: NA
-
Amino Acid-based Oral Rehydration Solution in Children With Short Bowel Syndrome
NCT03105362 ·Status: TERMINATED ·Phase: NA
-
Gastrointestinal Dysmotility on Aspiration Risk
NCT05455359 ·Status: RECRUITING ·Phase: PHASE4
-
Melatonin in Pediatric FD Population
NCT04684199 ·Status: COMPLETED ·Phase: NA
-
Electrogastrography (EGC) in Premature Infants With Feeding Intolerance
NCT00008736 ·Status: COMPLETED ·Phase: PHASE2
-
Short Peptide Formula for Bowel Preparation
NCT03742934 ·Status: COMPLETED ·Phase: NA
-
Three Dietary Regimens in Pre-colonoscopic Bowel Preparation in Children
NCT05609591 ·Status: COMPLETED ·Phase: NA